Dr. Usman's Cardiology Notes

Hypertrophic Cardiomyopathy (HCM) Guideline-Based Practical Review Evidence-based update for physicians, cardiology trainees, and electrophysiologists --- What is Hypertrophic Cardiomyopathy? Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy, affecting approximately 1 in 500 individuals. It is characterized by otherwise unexplained left ventricular hypertrophy, most commonly due to pathogenic sarcomeric gene mutations. The 2024 AHA/ACC Multisociety Guideline emphasizes early diagnosis, multidisciplinary care, genetic evaluation, shared decision-making, and individualized treatment rather than universal restrictions.  --- Diagnostic Criteria Diagnosis is established when: LV wall thickness ≥15 mm in adults without another cause of hypertrophy Wall thickness 13–14 mm may be diagnostic in first-degree relatives or genotype-positive individuals Exclude secondary causes such as: Hypertension Aortic stenosis Athlete's heart Cardiac amyloidosis Fabry disease Da...

 Clinical Indicators of Advanced HF.  I-NEED-HELP mnemonic

 LA/LAA Clot Classification Left Atrial (LA) and Left Atrial Appendage (LAA) Thrombus Classification Introduction Left atrial (LA) and left atrial appendage (LAA) thrombi are major sources of cardioembolic stroke, particularly in patients with Atrial Fibrillation, mitral valve disease, heart failure, and severe left atrial enlargement. Accurate characterization of thrombus morphology is important because thrombus size, mobility, and attachment influence embolic risk and procedural planning for cardioversion, catheter ablation, and LAA closure. Although no universally accepted classification system exists, LA/LAA thrombi are commonly categorized according to morphology, mobility, location, and chronicity. --- 1. Classification by Morphology Type I: Pedunculated (Mobile) Thrombus Attached to the atrial wall or LAA by a narrow stalk. Exhibits marked mobility during the cardiac cycle. Highest embolic potential. Can occasionally mimic an atrial myxoma. Clinical significance: Immediate a...

 Anticoagulation for Atrial Fibrillation in Valvular Heart Disease Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is a major risk factor for ischemic stroke. The presence of valvular heart disease (VHD) further increases the risk of thromboembolism, making appropriate anticoagulation a cornerstone of management. However, not all valvular lesions are treated the same way, and the choice between vitamin K antagonists and direct oral anticoagulants (DOACs) depends largely on the type of valve disease present. --- Why Does AF Increase Stroke Risk? In AF, ineffective atrial contraction leads to blood stasis, particularly within the left atrial appendage. This promotes thrombus formation, which can embolize to the cerebral circulation and cause stroke. Patients with valvular heart disease often have: Left atrial enlargement Elevated left atrial pressure Blood flow abnormalities Increased atrial fibrosis These factors further enhance the risk of thrombus form...

  Femoral Puncture Landmarks: Complete Practical Guide Femoral vascular access remains one of the most important procedural skills in cardiology, electrophysiology, interventional radiology, critical care, and emergency medicine. Safe puncture depends heavily on understanding surface anatomy, fluoroscopic landmarks, ultrasound guidance, and common pitfalls. --- Why Accurate Femoral Puncture Matters Incorrect puncture can lead to: Retroperitoneal hemorrhage Pseudoaneurysm Arteriovenous fistula Difficult hemostasis Vessel thrombosis Nerve injury Failed access The ideal puncture site balances: Easy vascular entry Adequate compression afterward Minimal complication risk --- Basic Anatomy of the Femoral Region Arrangement Under the Inguinal Ligament From lateral to medial: NAVEL N — Femoral Nerve A — Femoral Artery V — Femoral Vein E — Empty space L — Lymphatics The femoral vein lies: Medial to the artery near the inguinal ligament Posteromedial lower down This relationship changes dist...

  Blood Supply of the Conduction System Blood Supply of the Cardiac Conduction System The Lifeline Behind Every Heartbeat The human heart beats nearly 100,000 times each day with remarkable precision. Behind this rhythmic orchestration lies a specialized electrical network known as the cardiac conduction system. While clinicians often focus on ECG tracings and arrhythmias, an equally important aspect is frequently overlooked: the vascular supply that nourishes this delicate electrical machinery. Understanding the blood supply of the conduction system is essential for cardiologists, electrophysiologists, cardiac surgeons, intensivists, and trainees because ischemia involving these structures can produce devastating rhythm disturbances ranging from sinus node dysfunction to complete heart block. --- Why Does the Blood Supply Matter? The conduction system has exceptionally high metabolic demands. Even brief interruptions in perfusion can impair impulse generation or conduction. Ischem...

  Statin Recommendations in Chronic Kidney Disease Statin Recommendations in Chronic Kidney Disease (CKD) Why Statins Matter in CKD Patients with chronic kidney disease have a markedly increased risk of: Atherosclerotic cardiovascular disease (ASCVD) Myocardial infarction Stroke Cardiovascular mortality Statins reduce cardiovascular events in most CKD patients, especially in non-dialysis CKD. --- Who Should Receive Statins? 1. CKD Patients ≥50 Years Most adults with CKD aged ≥50 years should receive a statin regardless of baseline LDL level. Includes: CKD stages 1–5 not on dialysis eGFR <60 mL/min/1.73m² Albuminuria/proteinuria --- 2. CKD Patients 18–49 Years Statin therapy is recommended if one or more are present: Diabetes mellitus Known coronary artery disease Prior stroke Estimated 10-year ASCVD risk >10% Smoking Hypertension with high CV risk --- CKD Staging and Statin Use CKD Stage Statin Recommendation Stage 1–2 Treat similar to general population Stage 3–5 (non-dialys...